Overview

Escitalopram for the Treatment of Self-Injurious Skin Picking

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of escitalopram in treating self-injurious skin picking.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Forest Laboratories
Treatments:
Citalopram
Dexetimide